Learn more about investing in Kalia Health

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Kalia Health
Bringing healthcare home
Founded
2020
Employees*
2-10
* Data source: Crunchbase
Denali Dahl, CEO
“Preeclampsia is the second leading cause of maternal mortality worldwide. By providing a home based diagnostic test to detect symptoms earlier, we can reduce these numbers and save more lives.”
21.3 million pregnancies are affected by preeclampsia globally every year.

Kalia Health is dedicated to improving maternal health through engineering a safe, affordable, and accessible home-based early detection test for preeclampsia (PE). The lateral flow device identifies urinary biomarkers specific to PE for a more real-time diagnosis. This test will increase the number of birthing people that self-detect and seek prenatal care for PE through home diagnosis, education, and empowerment.